Home » Topics » Regulatory » Patents

Patents
RSS

Fujisawa describes ACE and/or NEP inhibitors

Nov. 15, 1996

Dual ACE/NEP inhibitors from Fujisawa

Nov. 15, 1996

HLE inhibitors reported by Japan Tobacco

Nov. 15, 1996

Daiichi discloses cerebroprotective agents

Nov. 15, 1996

Senju reports new compounds for treating allergic disorders

Nov. 15, 1996

Safer, more potent antipsychotic agents reported by HMR

Nov. 15, 1996

New antidepressants with improved safety reported by BMS

Nov. 15, 1996

Dutch researcher reports potential CNS agents

Nov. 15, 1996

Antipsychotic agents from Taisho

Nov. 15, 1996

Green Cross describes inhibitors of lipid oxidation

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.